[go: up one dir, main page]

CL2012001742A1 - Uso de tp3 como agente de acoplamiento para la prepa racion de un intermediario de combretastatina. - Google Patents

Uso de tp3 como agente de acoplamiento para la prepa racion de un intermediario de combretastatina.

Info

Publication number
CL2012001742A1
CL2012001742A1 CL2012001742A CL2012001742A CL2012001742A1 CL 2012001742 A1 CL2012001742 A1 CL 2012001742A1 CL 2012001742 A CL2012001742 A CL 2012001742A CL 2012001742 A CL2012001742 A CL 2012001742A CL 2012001742 A1 CL2012001742 A1 CL 2012001742A1
Authority
CL
Chile
Prior art keywords
combretastatin
preparation
coupling agent
amino
compound
Prior art date
Application number
CL2012001742A
Other languages
English (en)
Inventor
Marc Frederic
Sylviane Lutz
Joel Malpart
Philippe Masson
Stephane Mutti
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39816950&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2012001742(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of CL2012001742A1 publication Critical patent/CL2012001742A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/78—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C217/80—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
    • C07C217/82—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring
    • C07C217/84—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/16—Preparation of optical isomers
    • C07C231/18—Preparation of optical isomers by stereospecific synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Procedimiento que implica el uso de T3P en el acoplamiento entre un compuesto (Z) amino ((2-metoxi-5[(Z)-2-(3,4,5-trimetoxifenil) vinil]-anilina) o la sal del compuesto (Z) amino con derivado de L-serina. (Divisional de la Solicitud 463-2009).
CL2012001742A 2008-02-28 2012-06-25 Uso de tp3 como agente de acoplamiento para la prepa racion de un intermediario de combretastatina. CL2012001742A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0801092A FR2928148B1 (fr) 2008-02-28 2008-02-28 Procede de preparation de combretastatine

Publications (1)

Publication Number Publication Date
CL2012001742A1 true CL2012001742A1 (es) 2012-11-16

Family

ID=39816950

Family Applications (3)

Application Number Title Priority Date Filing Date
CL2009000463A CL2009000463A1 (es) 2008-02-28 2009-02-27 Procedimiento de preparacion de combretastatina por enriquecimiento de un alqueno y posterior acoplamiento con l-serina en presencia de t3p.
CL2012001744A CL2012001744A1 (es) 2008-02-28 2012-06-25 Procedimiento de enriquecimiento de la forma (z) de la sal de un estiben amina tetrametoxilada utilizando alcohol bencilico; util como compuesto intermediario en la preparacion de combretastatina (divisional de la sol. 463-2009).
CL2012001742A CL2012001742A1 (es) 2008-02-28 2012-06-25 Uso de tp3 como agente de acoplamiento para la prepa racion de un intermediario de combretastatina.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
CL2009000463A CL2009000463A1 (es) 2008-02-28 2009-02-27 Procedimiento de preparacion de combretastatina por enriquecimiento de un alqueno y posterior acoplamiento con l-serina en presencia de t3p.
CL2012001744A CL2012001744A1 (es) 2008-02-28 2012-06-25 Procedimiento de enriquecimiento de la forma (z) de la sal de un estiben amina tetrametoxilada utilizando alcohol bencilico; util como compuesto intermediario en la preparacion de combretastatina (divisional de la sol. 463-2009).

Country Status (28)

Country Link
US (1) US20110124899A1 (es)
EP (2) EP2252572A1 (es)
JP (1) JP2011513286A (es)
KR (1) KR20100116644A (es)
CN (1) CN102015620A (es)
AR (1) AR072772A1 (es)
AU (1) AU2009229027A1 (es)
BR (1) BRPI0907999A2 (es)
CA (1) CA2716541A1 (es)
CL (3) CL2009000463A1 (es)
CO (1) CO6241150A2 (es)
CR (1) CR11635A (es)
DO (1) DOP2010000250A (es)
EA (2) EA201300249A1 (es)
EC (1) ECSP10010421A (es)
FR (1) FR2928148B1 (es)
HN (1) HN2010001700A (es)
IL (2) IL207754A0 (es)
MA (1) MA32193B1 (es)
MX (1) MX2010009514A (es)
NI (1) NI201000144A (es)
NZ (1) NZ587505A (es)
PE (1) PE20091559A1 (es)
SG (1) SG183658A1 (es)
TW (1) TW200948753A (es)
UY (1) UY31681A1 (es)
WO (1) WO2009118474A1 (es)
ZA (1) ZA201006137B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2953518B1 (fr) 2009-12-03 2012-01-20 Sanofi Aventis Procede de preparation d'un derive de combretastatine
WO2013084150A1 (en) * 2011-12-06 2013-06-13 Sanofi Novel crystal form of (2s)-2-amino-3-hydroxy-n-[2-methoxy-2-[(1z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl]propanamide and method of preparation thereof
EP2805705B1 (en) 2013-05-23 2016-11-09 IP Gesellschaft für Management mbH Packaging with one or more administration units comprising a sodium salt of (R)-3-[6-amino-pyridin-3-yl]-2-(1-cyclohexyl-1 H-imidazol-4-yl)-propionic acid
CN104447598B (zh) * 2013-09-18 2017-09-22 浙江大德药业集团有限公司 Ca‑4的大环多胺衍生物及其抗肿瘤特性
CN104817519B (zh) * 2015-05-11 2016-11-16 中国药科大学 一类ca-4的衍生物、其制法及其医药用途
CN104892668B (zh) * 2015-05-12 2017-03-29 上海大学 考布他汀类似物水溶性前‑前药及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1217500A (en) * 1967-05-24 1970-12-31 Ici Ltd Separation of trans-trans enriched salts of 4,4'-diaminodicyclohexylmethane
TW325458B (en) 1993-09-08 1998-01-21 Ajinomoto Kk Stilbene derivatives and pharmaceutical compositions comprising the same for anti-cancer
US5731353A (en) 1993-09-08 1998-03-24 Ajinomoto Co., Inc. Stilbene derivatives and pharmaceutical compositions containing them
US5561122A (en) 1994-12-22 1996-10-01 Arizona Board Of Regents Acting On Behalf Of Arizona State University Combretastatin A-4 prodrug
TW334418B (en) * 1995-03-07 1998-06-21 Ajinomoto Kk Stilbene derivatives and pharmaceutical compositions
JPH08272028A (ja) * 1995-03-30 1996-10-18 Fuji Photo Film Co Ltd ハロゲン化銀写真感光材料およびその製造方法
JP2000239274A (ja) * 1998-12-16 2000-09-05 Nippon Kayaku Co Ltd 新規ナフチリジン誘導体の製造法
ATE354358T1 (de) * 1999-12-21 2007-03-15 Teva Pharma Neue sertralinhydrochlorid polymorphe, verfahren zur herstellung und zur verwendung und diese enthaltende zusammensetzungen
FR2838437B1 (fr) * 2002-04-11 2004-06-04 Aventis Pharma Sa Procedes de preparation de combretastatines
US6759555B2 (en) * 2002-04-11 2004-07-06 Aventis Pharma S.A. Process for the preparation of combretastatins
DE10333042B4 (de) * 2003-07-21 2005-09-29 Clariant Gmbh Verfahren zur Herstellung von cyclischen Phosphonsäureanhydriden und deren Verwendung

Also Published As

Publication number Publication date
CA2716541A1 (fr) 2009-10-01
CN102015620A (zh) 2011-04-13
PE20091559A1 (es) 2009-10-30
CO6241150A2 (es) 2011-01-20
KR20100116644A (ko) 2010-11-01
AU2009229027A1 (en) 2009-10-01
SG183658A1 (en) 2012-09-27
EP2562154A1 (fr) 2013-02-27
EP2252572A1 (fr) 2010-11-24
MX2010009514A (es) 2010-12-15
FR2928148B1 (fr) 2013-01-18
IL207754A0 (en) 2010-12-30
CR11635A (es) 2011-02-04
NZ587505A (en) 2012-06-29
MA32193B1 (fr) 2011-04-01
CL2009000463A1 (es) 2010-12-03
UY31681A1 (es) 2009-09-30
HN2010001700A (es) 2013-06-17
CL2012001744A1 (es) 2012-10-12
EA201071001A1 (ru) 2011-02-28
WO2009118474A8 (fr) 2010-09-10
FR2928148A1 (fr) 2009-09-04
IL225776A0 (en) 2013-06-27
DOP2010000250A (es) 2010-09-30
NI201000144A (es) 2011-03-09
AR072772A1 (es) 2010-09-22
ZA201006137B (en) 2011-11-30
ECSP10010421A (es) 2010-09-30
TW200948753A (en) 2009-12-01
US20110124899A1 (en) 2011-05-26
EA201300249A1 (ru) 2013-08-30
WO2009118474A1 (fr) 2009-10-01
BRPI0907999A2 (pt) 2019-01-15
JP2011513286A (ja) 2011-04-28

Similar Documents

Publication Publication Date Title
CL2012001742A1 (es) Uso de tp3 como agente de acoplamiento para la prepa racion de un intermediario de combretastatina.
CR10157A (es) Compuestos químicos
CL2008001024A1 (es) Compuestos derivados de ftalazinona; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de enfermedades cardiovasculares, parkinson, enfermedades inflamatorias, esclerosis multiple, cancer, entre otras
NI201000044A (es) Bromhidrato de bupropión y aplicaciones terapéuticas
CL2010000188A1 (es) Metodo para el tratamiento de una infeccion en un sujeto que comprende la administracion de 9-[(2,2-dimetil-propilamino)-metil]-minociclina o de una sal de la misma; composicion farmaceutica que comprende dicho compuesto; y su uso.
BRPI0714558A8 (pt) processo para a preparação de (1r,2r)-3-(3-dimetilamino-1-etil-2-metil-propil)-fenol
CL2013003146A1 (es) Formulación estable que comprende anticuerpo anti alfa 4 beta 7 y al menos un aminoacido libre; metodo para preparar la formulación; uso para tratar enfermedad inflamatoria.
ES2620742T3 (es) Formulaciones de principio activo que contienen 2-tiazol-4il-1H-benzoimidazol (tiabendazol o TBZ) para la fabricación de WPC
UA103319C2 (en) Thiazole- and oxazole-benzene sulfonamide compounds
CL2011001811A1 (es) Un metodo para tratar un paciente que ha sufrido un infarto agudo al miocardio que comprende el uso de un agente antifibrotico.
CL2009000990A1 (es) Uso de epotilona d para el tratamiento de enfermedades asociadas a tau, tal como enfermedad alzheimer, parkinson, entre otras.
CL2008001821A1 (es) Compuestos derivados de imidazo[2,1-b]-tiazol; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de diabetes, sindrome metabolico, resistencia a la insulina, entre otras.
CR9786A (es) Compuestos de bencimidazol-tiofeno
ECSP11011151A (es) Compuestos purina
CL2011000135A1 (es) Uso de una fromulacion farmaceutica acuosa que comprende 0,5-10% de terbinafina o una sal de la misma, 2-10% de un fosfolipido y 1-5% de un surfactante, para preparar un medicamento util para tratar una infeccion fungica; formulacion farmaceutica.
DOP2010000134A (es) Algunos derivados de 2-pirazinona como inhibidores de elastasa de los neutrofilos
BRPI0618239A8 (pt) uso de flibanserina para o tratamento de distúrbios de desejo sexual pré-menopáusicos
WO2009140061A3 (en) Aminoalcohol and biocide compositions for aqueous based systems
CR11259A (es) Bromhidrato de bupropion y aplicaciones terapueticas
GT201000047A (es) Mejoras en compuestos organicos o relacionadas con los mismos
AR061545A1 (es) Tableta que contiene candesartan cilexetilo
TW200942524A (en) Novel aminomethyl benzene derivatives
PE20080949A1 (es) Azolilmetiloxiranos, su uso para combatir hongos fitopatogenos, asi como productos que los contienen
CL2012003341A1 (es) Composicion farmaceutica de administracion oral que compende bendamustina o un ester, una sal o un solvato de la misma, y un excipiente que es un agente tensioactivo no ionico e hidrofilico; combinacion farmaceutica; y su uso para el tratamiento de leucemia linfocitica cronica y el mieloma multiple, entre otras enfermedades.
WO2009102808A3 (en) Doxorubicin adjuvants to reduce toxicity and methods for using the same